{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:02:07Z","timestamp":1764997327544,"version":"3.44.0"},"reference-count":11,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,6,14]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>A 72-year-old Japanese man treated with omeprazole for 11 years was admitted due to loss of consciousness and muscle weakness. Wolff-Parkinson-White syndrome-induced tachycardia was considered as the cause of syncope. His blood examination revealed rhabdomyolysis, hypokalaemia, hypomagnesaemia, hypocalcaemia, hyperlactacidaemia, hyperammonaemia and high-anion-gap metabolic acidosis. Hypomagnesaemia could be caused by magnesium malabsorption due to omeprazole use. Hypocalcaemia might be caused by the inhibitory effect of hypomagnesemia on the parathyroid gland hormone secretion. Hyperammonaemia might be caused by two reasons: (1) renal ammonium production induced by hypokalaemia; (2) inhibition of ammonium secretion by omeprazole. Both hypocalcaemia and hypokalaemia might cause chronic elevation of serum creatinine phosphokinase which ended up with rhabdomyolysis. Correction of serum electrolytes rapidly improved his muscle weakness. Discontinuation of omeprazole no longer caused these abnormalities. A physician should be aware of unexplained signs and symptoms of patients using proton-pump inhibitors to avoid life-threatening electrolyte and physiologic disturbances.<\/jats:p>","DOI":"10.1136\/bcr-2020-235385","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T02:12:48Z","timestamp":1594260768000},"page":"e235385","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5283-1592","authenticated-orcid":false,"given":"Naohi","family":"Isse","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ako City Hospital, Ako, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ako City Hospital, Ako, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"2025082702364677000_13.7.e235385.1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5056\/jnm18001","article-title":"Advantages and disadvantages of long-term proton pump inhibitor use","volume":"24","author":"Kinoshita","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"doi-asserted-by":"publisher","key":"2025082702364677000_13.7.e235385.2","DOI":"10.5527\/wjn.v5.i2.152"},{"doi-asserted-by":"publisher","key":"2025082702364677000_13.7.e235385.3","DOI":"10.1053\/j.ajkd.2009.11.019"},{"key":"2025082702364677000_13.7.e235385.4","first-page":"525","article-title":"Review of the diagnostic evaluation of renal tubular acidosis","volume":"16","author":"Yaxley","year":"2016","journal-title":"Ochsner J"},{"doi-asserted-by":"publisher","key":"2025082702364677000_13.7.e235385.5","DOI":"10.1681\/ASN.2007070792"},{"unstructured":"Emmett M , Palmer BF . Urine anion and osmolal gaps in metabolic acidosis - UpToDate. Topic 2348 Version 23.0. Available: https:\/\/www.uptodate.com\/contents\/urine-anion-and-osmolal-gaps-in-metabolic-acidosis?sectionName=Limitations of the UAG&search=Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis&topicRef= [Accessed 10 Mar 2020].","key":"2025082702364677000_13.7.e235385.6"},{"doi-asserted-by":"publisher","key":"2025082702364677000_13.7.e235385.7","DOI":"10.1111\/j.1365-2036.2012.05201.x"},{"doi-asserted-by":"publisher","key":"2025082702364677000_13.7.e235385.8","DOI":"10.1210\/jcem-61-5-933"},{"doi-asserted-by":"publisher","key":"2025082702364677000_13.7.e235385.9","DOI":"10.1136\/bmj.327.7407.115"},{"unstructured":"Emmett M , Palmer BF . Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis - UpToDate. Topic 2328 Version 24.0. Available: https:\/\/www.uptodate.com\/contents\/etiology-and-diagnosis-of-distal-type-1-and-proximal-type-2-renal-tubular-acidosis?source=history_widget#H7 [Accessed 10 Mar 2020].","key":"2025082702364677000_13.7.e235385.10"},{"key":"2025082702364677000_13.7.e235385.11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1053\/j.ackd.2018.05.005","article-title":"Renal Tubular Acidosis: H+\/Base and Ammonia Transport Abnormalities and Clinical Syndromes","volume":"25","author":"Kurtz","year":"2018","journal-title":"Adv Chronic Kidney Dis"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-235385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:36:52Z","timestamp":1756287412000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-235385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":11,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,8]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/bcr-2020-235385"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-235385","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}